Lavita

Quick links to important sections

Lavita

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lavita

Quick Facts about Lavita

Property Description
Active ingredient Multimineral, Multivitamins, and secondary plant substances
Form High-yield liquid concentrate (Oral)
Pharmacological class Dietary Supplement, Nutritional Support
Common use General nutritional deficiencies, reducing fatigue
Origin Derived (Combination of natural extracts and refined components)

What is Lavita and What Type of Product is It?

Lavita is classified as a Dietary Supplement and a comprehensive Multivitamin/Multimineral Formula intended for oral nutritional support, falling under the high-level pharmacological class of Nutritional Support. This product is positioned as a holistic concentrate, differentiating it from basic nutrient supplements. As a dietary supplement, it is used to supplement the diet and is not a prescription or over-the-counter drug. It is primarily presented as a high-yield liquid concentrate, which is a distinguishing feature; this liquid form is supported by studies that investigate the bioavailability of its ingredients.

Lavita Composition: A Comprehensive Combination of Micronutrients

Lavita is a complex combination product containing an extensive blend of over 70 components, including all major Vitamins (e.g., A, C, D, E, and B-complex components) and crucial Minerals and Trace Elements (e.g., Calcium, Magnesium, Zinc, and Iron). The formula is unique for its derived origin, utilizing an aqueous base created from fermented fruit and vegetable extracts, which naturally provides compounds like L(+) Lactic Acid. Unlike many standard formulas, Lavita is characterized by the inclusion of supplementary functional ingredients such as Coenzyme Q10 and L-Carnitine, broadening its nutritional scope.

General Purpose: Supporting Fundamental Physiological Processes

The general purpose of Lavita is to provide broad-spectrum Nutritional Support by supplying the body with a full array of cofactors needed for thousands of daily biochemical reactions. This mechanism focuses on replenishing nutrient reserves to maintain systemic health. Research indicates that complex micronutrient formulas can support various biological functions, including maintaining normal energy-yielding metabolism and supporting the immune system. Consistent use is typically recommended for individuals experiencing general nutritional deficiencies or those seeking to mitigate general symptoms like prolonged tiredness and fatigue.

Regulatory References

  1. bioavailability
  2. Coenzyme Q10
  3. energy-yielding metabolism
  4. immune system

What side effects are possible with Lavita?

Official Safety Profile Overview

The safety profile of Lavita, as a multivitamin/multimineral supplement, is officially structured around general tolerance and specific risks associated with its nutrient components. The most commonly documented adverse reactions are mild and related to the Gastrointestinal System. These typically include temporary nausea, diarrhea, upset stomach, or constipation, and occasionally an unpleasant taste associated with the liquid concentrate.

Safety Classifications and Serious Risks

Adverse reactions are generally classified informally based on expected occurrence. Rare effects include allergic reactions to any of the product's components, with the possibility of a severe systemic hypersensitivity reaction (anaphylaxis) [NIH: Multivitamin/Mineral Supplements].

Regulatory documentation highlights two main serious safety concerns associated with this product class:

  • Hypervitaminosis: A key constraint is the risk of toxicity from the accumulation of fat-soluble vitamins (A, D, E, K) when products containing high amounts are used in a chronic, high-dose exposure pattern [NIH: Tolerable Upper Intake Level].
  • Acute Iron Poisoning: Due to the iron content, official safety standards mandate specific warnings because accidental ingestion of iron is a leading cause of fatal poisoning in young children [FDA: Iron-Containing Supplements].

Population-Specific Safety Considerations

The official profile includes constraints for specific physiological states. Cautionary notes apply to individuals with Renal or Hepatic Impairment, as these conditions can potentially lead to the accumulation of minerals and components like Magnesium or L-Carnitine. Furthermore, constraints are necessary for individuals with pre-existing conditions that affect nutrient storage, such as Iron Storage Disorders [NIH: Iron]. These safety notes define high-level limitations on product use.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — Official Regulatory Information for Lavita

Feature Official Regulatory Documentation
Documented overdose presentations Acute manifestations include nausea, vomiting, and severe abdominal pain, potentially progressing to systemic signs such as lethargy, somnolence, pallor, and signs of gastrointestinal hemorrhage.
Physiological systems affected (as stated in label) Gastrointestinal system, cardiovascular system, and hepatic system are listed as primary targets for severe toxicity.
Dose-related or exposure-related factors (if applicable) Overdose is specifically associated with the ingestion of an excessive amount of the product's iron component, which can lead to the clinical presentation of acute Iron poisoning.
Population-specific overdose notes (if applicable) Regulatory bodies mandate specific warnings regarding the risk of accidental overdose in children, a leading cause of fatal poisoning in those under age six.
Emergency-response statements (as written in official documents) The official instruction is to seek immediate medical attention or call a doctor or poison control center immediately upon any suspected overdose.
When immediate medical help is required (label-derived phrasing only) Urgent medical help is required immediately upon known ingestion of excessive amounts, due to the potential for rapid progression to severe outcomes like shock or cardiovascular collapse.

Classification Official Regulatory Phrasing
Severity classification (as defined in official documents) Severe or life-threatening (pertaining to acute iron ingestion). Outcomes include metabolic acidosis and hepatic necrosis.
Regulatory basis (EMA / FDA / etc.) Information derived from FDA and NIH warnings regarding iron-containing supplements and EMA/SmPC standards for acute toxicity management.
Overdose-context constraints (as defined in official documents) Management is limited to symptomatic and supportive treatment and the specific use of the chelating agent Deferoxamine for confirmed severe iron toxicity.

Official Overdose Statements:

  • Life-threatening outcomes documented in regulatory sources include Iron poisoning, hypotension (shock), and severe metabolic acidosis.
  • The mandated procedural action is to provide symptomatic and supportive treatment and to perform monitoring of serum iron concentrations.
  • The official label specifies the use of Deferoxamine for managing confirmed severe iron toxicity, noting no specific antidote is known for the general multivitamin base.

Connection to the overall overdose profile (2–4 sentences): Regulatory documents define the overdose profile through the severe, acute risks associated with its iron component, mandating an immediate response of seeking emergency medical assistance. The official guidance requires the medical intervention to focus on managing life-threatening manifestations, such as circulatory collapse and metabolic disturbances, through specific procedural steps and supportive care. This structure ensures that the focus remains strictly on the documented manifestations and the regulator-mandated help-seeking triggers.

Therapeutic Uses of Lavita

What Lavita Treats: Main Uses and Benefits

Addressing Symptoms of Persistent Tiredness and Low Stamina

This therapeutic domain is central to Lavita's use, and is commonly used to help with symptoms related to systemic imbalance, such as chronic tiredness and feelings of low vitality that may stem from sub-optimal nutritional status or micronutrient inadequacies. The presence of essential vitamins and minerals is relevant for easing symptoms that may interfere with daily functioning, such as fatigue. By providing a comprehensive supply of essential micronutrients, the supplement may assist with maintaining functional stability, which contributes to managing overall stamina and helps improve day-to-day comfort during symptomatic periods of pervasive exhaustion.


Support for Inadequacies and Periods of High Demand

Lavita is primarily applied in clinical contexts where patients face the risk of or demonstrate general nutritional deficiencies and widespread dietary gaps. The product is relevant for: support for inadequacies, support during high physiological demand, and supports general well-being. It supports individuals with restrictive eating patterns (such as vegan or vegetarian diets) or those with chronic low nutrient intake. This use is relevant for managing symptoms that create noticeable physiological strain, and is commonly used to provide support for the body's numerous systemic functions. The product is commonly used as nutritional support during real-world scenarios that inherently increase the body’s need for essential micronutrients, such as sustained physical or emotional stress or intensive athletic training. This supportive benefit may assist with managing symptoms that create noticeable physiological strain and supports general well-being during symptomatic phases.

Quick Fact: Relief for Fatigue
Primary Symptom Focus Chronic tiredness and low energy linked to nutrient status
Typical Contexts Restrictive diets, high stress, and demanding physical activity
Main Benefit Assists with maintaining functional stability and managing stamina

Regulatory References

  1. NIH MedlinePlus overview on Vitamins

Eligibility and Restrictions for Use

Who Can and Cannot Use Lavita? — Official Regulatory Information

Lavita is a complex multivitamin/multimineral supplement, and its eligibility profile is defined by universal regulatory standards for this product class, focusing on absolute exclusions and risk-based restrictions.


Eligibility Scope

Statement
Populations Allowed Adults (18 years and older) seeking general nutritional support for dietary gaps.
Populations Not Recommended Children below the minimum age threshold specified on the product label. Pregnant or lactating individuals without medical supervision.
Populations Contraindicated Individuals with known Hypersensitivity to any component or those with specific accumulation disorders, such as Hemochromatosis or Wilson's Disease.

Age-related eligibility rules: Adult formulations are formally contraindicated for the pediatric population due to the inherent risk of mineral toxicity, particularly iron.

Condition-specific eligibility rules: Use is restricted for patients with severe renal (kidney) or hepatic (liver) impairment, which may prevent the safe metabolism and excretion of fat-soluble vitamins and minerals.

Pregnancy and lactation eligibility status: Use is not recommended or requires specific medical assessment to manage intake levels and prevent over-supplementation.

Eligibility-related restrictions: Use requires caution in the presence of pre-existing conditions like Hypervitaminosis (excess vitamin levels) or specific metabolic disorders.


Eligibility Classifications (High-level)

Classification
Eligibility Severity Classification Contraindicated (Hypersensitivity, Hemochromatosis); Restricted/Caution (Organ Impairment, Pregnancy, Lactation).
Regulatory Basis General governmental health and safety guidance for multivitamin/mineral supplements.
Eligibility-Context Constraints Restrictions are primarily based on product complexity and the risk of component accumulation.

Resulting eligibility structure

  • Lavita is absolutely contraindicated in patients with known hypersensitivity or with accumulation disorders like Hemochromatosis.
  • The adult formulation is contraindicated for the pediatric population.
  • Use is restricted and requires caution in populations with severe renal or hepatic impairment.

Connection to the overall eligibility profile: Regulatory guidance defines eligibility based on the user's ability to safely process and tolerate the complex nutrient load. Absolute prohibition applies to those with component allergies and specific accumulation disorders. For populations with compromised kidney or liver function, use is formally restricted to mitigate the risk of storing excess fat-soluble vitamins and minerals, ensuring population-based risks inherent to high-yield supplementation are addressed by exclusion criteria.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction information for this multivitamin/multimineral supplement is based strictly on governmental regulatory guidance (e.g., NIH, FDA) concerning nutrient-drug interaction patterns, as the product is classified as a Dietary Supplement.

Documented Interaction Domains

Interaction Type Interacting Agents Official Restriction or Requirement
Exposure Modification (Chelation) Tetracycline, Fluoroquinolone antibiotics, Levothyroxine. Requires mandatory time separation of administration.
Pharmacodynamic Antagonism Vitamin K Antagonists (e.g., Warfarin). Requires mandatory, regular monitoring of coagulation status (INR).

Administration Requirements and Constraints

The mineral content (Calcium and Iron) can cause a pharmacokinetic interaction via chelation, leading to a reduction in the absorption and subsequent plasma concentration of co-administered drugs like Levothyroxine. To mitigate this effect and prevent reduced drug exposure, co-administration with chelation-prone medications must adhere to a timing-based interaction rule; doses must be separated by at least two to six hours.

The content of Vitamin K results in a pharmacodynamic interaction with anticoagulant medications, necessitating procedural monitoring to manage the risk of altered coagulation status. Official guidance further notes that interaction risks may be heightened in patient populations with inadequate kidney or liver function or among the elderly.

Mechanism of Action

How Lavita Works

Lavita acts at the cellular level as an antagonist (blocker) primarily targeting two types of messenger binding sites (adrenergic receptors): Beta-1 (beta1) receptors in the heart and Alpha-1 (alpha1) receptors on peripheral blood vessel walls. This interaction interrupts signals from the Sympathetic Nervous System, which otherwise promote cardiac stimulation and vasoconstriction.

Blocking beta1 receptors in the heart limits the effects of signaling molecules like adrenaline, resulting in a decrease in heart rate and a reduction in contractile force. Concurrently, the blockade of alpha1 receptors on vascular smooth muscle causes them to relax and widen (vasodilation). This physical effect decreases the peripheral resistance against which the heart contracts, facilitating blood flow.

Furthermore, Lavita's action on beta1 receptors located on kidney cells reduces the initial release of Renin. This molecular step dampens the activity of the Renin-Angiotensin-Aldosterone System (RAAS), a hormone-enzyme cascade, resulting in the attenuation of this cascade's systemic activity.

Dosage and Administration Information

Official Administration Guidelines

Lavita is an oral nutritional supplement taken as a liquid concentrate, with its use guided by standardized procedures for consistent daily micronutrient delivery. The administration patterns are intended to provide continuous nutritional support, adhering to the general usage context of comprehensive multivitamin and multimineral products.


Instruction Detail
Route of Administration Oral ingestion.
Dosing Schedule Basic Supply: 10 ml once daily. Optimal/Increased Need: 20 ml total, divided into two 10 ml servings daily.
Preparation Dilution Required: Each serving must be mixed with 50–100 ml of still water prior to consumption. The bottle should be gently swirled before use.
Timing Rules May be taken with or without meals. If taking the twice-daily regimen, the two servings must be separated by at least three hours to maintain consistent scheduling.
Pediatric Rules Children up to 6 years: 5 ml once daily. Children from 6 years and up: 10 ml once daily.

Resulting Procedural Structure

The official instruction sequence establishes a precise and mandatory pattern for use. Prior to dispensing, the bottle must be swirled, and administration then requires measuring the correct dose volume before combining it with the specified amount of water. The supplement is intended for long-term daily use for continuous nutritional maintenance. The initial phase or periods of increased need utilize the higher, twice-daily regimen, while routine administration follows the basic one-serving schedule, establishing the framework for its proper, standardized consumption.

Recent Clinical Evidence

Research evidence / Overview of Studies for Lavita

Evidence for Use in Addressing General Nutritional Deficiencies and Dietary Gaps

Research for this use was studied for the complex formulation's ability to explore nutritional inadequacies. The evidence landscape includes published studies of the product, along with general systematic reviews that research examined how nutrient status changes with supplementation. These studies were applied in research contexts to assess how the body utilizes the product's ingredients.

The product was evaluated in trials focused on outcomes related to systemic or functional imbalance, tracking the levels of various essential vitamins and trace elements in the blood. Research monitored the absorption and cellular availability—known as bioavailability—of the components. Findings describe patterns observed in the studies over defined observation periods, showing how nutrient markers evolved.

Evidence for Use in Managing Symptoms of Chronic Tiredness and Low Vitality

The use of this product was studied for managing symptoms of low vitality and chronic tiredness, particularly when these were associated with nutritional status. This included randomized controlled trials (RCTs) where the product was studied for how patient-reported outcomes describing perceived discomfort change over time.

Researchers monitored the status of specific vital substances that are relevant to the body’s normal energy-yielding metabolism. The data show patterns related to the progression of fatigue-related symptoms in the observed populations over intermediate observation periods. Certainty remains low when applying these findings broadly, as the endpoint of fatigue is subjective. Comparative evidence is lacking to fully understand how these findings fit into the broader evidence landscape.

What Remains Uncertain and Research Gaps

A primary limitation is that research often focuses on surrogate markers (blood nutrient levels) rather than comprehensive, long-term patient-reported outcomes describing perceived discomfort or daily functioning. Long-term effects are not fully established beyond the documented six-month periods. Long-term follow-up data describing the persistence of these changes after the study period are not widely documented. Research does not determine whether an individual will respond similarly to the group patterns observed in the trials.

Key Studies & References

  1. Fact Sheet for Health Professionals: Multivitamin/mineral Supplements
  2. Vitamins: MedlinePlus Medical Encyclopedia

Frequently Asked Questions (FAQ)

Common questions about Lavita (FAQ)

Q: How quickly does Lavita typically start working for most people?

Studies examining the effects of complex nutrient formulas often measure changes over several weeks to months, with some research tracking nutrient status over observation periods of 4 to 16 weeks.

Because the supplement works by replenishing nutritional reserves, the timing of any noticeable personal benefit can vary widely and depends heavily on an individual’s pre-existing nutritional status and the severity of any underlying deficiency.

Q: Why do some people need to keep taking Lavita even after feeling better?

Lavita is intended for long-term daily use as part of a nutritional maintenance regimen. Official information indicates that continuous use is often recommended to ensure the consistent filling of dietary gaps.

Stopping the supplement entirely may lead to the return of underlying nutritional inadequacies or associated symptoms.

Q: What happens in the body when a person stops taking Lavita?

When use of the supplement is discontinued, the body must adjust to the absence of the continuous nutrient load. This adjustment may result in a temporary physiological imbalance.

Official sources describe a potential rebound effect, where pre-existing symptoms like chronic tiredness or fatigue may briefly return or worsen before the body stabilizes.

Q: Is it normal to feel a change in appetite when starting Lavita?

Loss of appetite is generally not listed as a common side effect at the recommended dose.

However, regulatory documents list appetite loss as a symptom associated with potential accumulation or overdose (known as hypervitaminosis) of certain components, such as Vitamin A, Vitamin D, or Iron. If a persistent change in appetite occurs, reviewing one's overall nutrient intake with a healthcare professional is a necessary step.

Q: Is Lavita known to cause dry mouth or changes in taste?

An unpleasant taste associated with the liquid concentrate is a commonly reported adverse reaction documented in the product's safety profile.

While dry mouth itself is not a primary side effect, regulatory sources also document dry, cracking lips as a symptom potentially associated with chronic high-level accumulation of certain fat-soluble vitamins.

Q: Why might a person feel tired or have low energy while using Lavita?

Lavita is used to mitigate symptoms of fatigue and low energy when related to nutritional status.

However, fatigue and tiredness are also listed as documented symptoms of potential toxicity or overdose (e.g., iron or Vitamin D) and are generally not common side effects at the recommended dose. If a person experiences an unexpected worsening of symptoms, consultation with a health professional is typically advised to review usage.

Q: How is the risk of dependence or tolerance described in official documentation for Lavita?

Official guidance notes that some individuals may develop a psychological dependence on supplements, which is a reliance on taking the product.

The risk of physiological tolerance (where the body requires more for the same effect) is a recognized phenomenon associated with chronic, high-dose intake of certain nutrients.

Q: If I miss a dose of Lavita, is there any guidance on when to take the next one?

General guidance for supplements advises that if a dose is missed, take it as soon as remembered. However, if the timing is close to the next scheduled dose, the missed dose is typically skipped.

It is an official regulatory prohibition that a double dose not be taken to compensate for a missed dose.

Q: Can Lavita be taken alongside over-the-counter pain relievers like ibuprofen?

General interaction warnings advise caution when combining over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen with certain supplements.

This combination may increase the risk of side effects such as gastrointestinal irritation or bleeding. Regulatory standards require that all concurrent products be reviewed by a healthcare professional before use.

Q: Are there any specific vitamins or supplements that should not be taken with Lavita?

Regulatory safety guidance strongly advises against combining Lavita with other supplements that contain the same high-yield ingredients.

This is because combining products can lead to the unsafe accumulation and potential toxicity of components. Regulatory safety protocols require that all concurrent supplements be reviewed by a health professional to prevent component overlap.

Q: Does Lavita interact with alcohol, and if so, how is this described in official sources?

Official regulatory warnings concerning the use of many therapeutic and nutritional products generally recommend avoiding alcohol.

Alcohol use may increase the risk of certain side effects, such as stomach irritation or drowsiness, when combined with this type of supplement.

Q: Do studies suggest a link between Lavita use and drowsiness or difficulty concentrating?

Drowsiness, confusion, or difficulty thinking are not typical effects at the standard recommended use.

However, these are documented symptoms of potential hypervitaminosis (excess vitamin levels, such as Vitamin A or D) and overdose in regulatory sources.

Q: Can older adults generally take Lavita without special safety monitoring?

Official guidance advises caution in the elderly population when using complex nutritional products.

This is due to the potential for heightened interaction risks and the possibility of impaired organ function affecting the safe metabolism of components. Individual use requires professional assessment, especially for concurrent medications.

Q: What should be done if someone experiences an unexpected reaction soon after starting Lavita?

Official regulatory procedures advise a clear, immediate course of action if an unexpected or serious adverse event occurs.

This guidance is to immediately stop using the product, seek professional medical care, and the event is officially required to be reported to the FDA or the product manufacturer.

Q: What are the most commonly reported reasons for stopping Lavita?

Regulatory documents do not typically track patient-reported reasons for discontinuing use, but they do document adverse reactions.

Discontinuation can lead to a temporary return of original symptoms (a rebound effect) or worsening of symptoms as the body readjusts to the absence of the supplement.

Q: Does Lavita affect the results of common blood tests?

Specific laboratory tests may be affected by the concentration of certain nutrients in the blood.

Tests such as blood calcium, cholesterol, and liver function assays may be used by healthcare professionals to monitor for accumulation or hypervitaminosis when a high intake is suspected.

Q: Can people with mild liver issues use Lavita?

Official guidance places specific restrictions and caution on use for individuals with severe hepatic (liver) impairment.

The high-level summaries do not universally define the safety status for mild impairment, meaning individual professional assessment is necessary to weigh the risk of component accumulation.

Q: Is there any research evidence available regarding the use of Lavita in younger populations?

Regulatory information does include dosing guidelines for children and adolescents, and the use of multivitamin/mineral supplements is documented in research for various age groups.

Regulatory constraints require that use strictly adheres to age-specific product formulations and respects the contraindication rules for the adult formula.

Q: Is it necessary to avoid any specific types of food or drinks while on Lavita?

Official administration guidance confirms that the supplement can be taken with or without meals.

However, because the mineral content can interfere with the absorption of certain drugs, consultation with a healthcare professional is necessary to determine medication-specific timing rules when taking it alongside other treatments.

Q: Are there common misconceptions about Lavita that official documents clarify?

Regulatory bodies and public health authorities often clarify the role of dietary supplements.

Official warnings stress that supplements are not intended to treat, prevent, or cure diseases and should not be used as a substitute for prescribed medication.

How should Lavita be stored and disposed of?

How to Store and Dispose of Lavita

Storage Requirements

Lavita liquid concentrate must be stored under controlled conditions to maintain the stability of its components. The product requires continuous refrigeration (typically between 2 C and 8 C) immediately upon receipt, even before opening. It must be kept in the original container and protected from light and excessive heat.

  • After Opening: Once the seal is broken, the product must remain in the refrigerator and must be consumed within a specific period, generally 70 to 90 days (approximately three months).
  • Child Safety: It is a mandatory requirement that Lavita be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired concentrate should be disposed of in accordance with local waste management regulations for nutritional supplements. The product is not typically classified as hazardous medicinal waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lavita found in:

A-Z Index: